CAS: 457947-61-4
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Methyl 4-AMino-5-chloro-2-Methoxy-3-nitrobenzoate REF: IN-DA00DLH5CAS: 457947-61-4 | 95% | To inquire | Tue 10 Dec 24 |
 | Methyl 4-amino-5-chloro-2-methoxy-3-nitrobenzoate REF: 10-F783621CAS: 457947-61-4 | 98% | To inquire | Fri 20 Dec 24 |
 | Methyl 4-Amino-5-chloro-2-methoxy-3-nitrobenzoate REF: TR-M285890CAS: 457947-61-4 | - - - | - - - | Discontinued product |
 | Methyl 4-amino-5-chloro-2-methoxy-3-nitrobenzoate REF: 3D-HTA94761CAS: 457947-61-4 | Min. 95% | - - - | Discontinued product |
Methyl 4-AMino-5-chloro-2-Methoxy-3-nitrobenzoate
CAS:457947-61-4
Formula:
C9H9ClN2O5
Purity:
95%
Color and Shape:
Solid
Molecular weight:
260.6312
Ref: IN-DA00DLH5
| 100mg | 157.00 € | ||
| 250mg | 233.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Methyl 4-amino-5-chloro-2-methoxy-3-nitrobenzoate
CAS:457947-61-4
Purity:
98%
Molecular weight:
260.6300048828125
Ref: 10-F783621
| 100mg | To inquire | ||
| 250mg | To inquire |
Estimated delivery in United States, on Friday 20 Dec 2024
Methyl 4-Amino-5-chloro-2-methoxy-3-nitrobenzoate
CAS:457947-61-4
Applications Methyl 4-Amino-5-chloro-2-methoxy-3-nitrobenzoate is an intermediate formed in the synthesis of (3,4-Di-[4-(2-carboxyethylcarbamoyl)phenylazo]salicylic Acid (D431100), an …
Formula:
C9H9ClN2O5
Color and Shape:
Yellow Solid
Molecular weight:
346.287
Ref: TR-M285890
| 1g | Discontinued | Request information | |
| 100mg | Discontinued | Request information |
Methyl 4-amino-5-chloro-2-methoxy-3-nitrobenzoate
CAS:457947-61-4
Please enquire for more information about Methyl 4-amino-5-chloro-2-methoxy-3-nitrobenzoate including the price, delivery time and more …
Formula:
C9H9ClN2O5
Purity:
Min. 95%
Molecular weight:
260.63 g/mol
Ref: 3D-HTA94761
| 1g | Discontinued | Request information | |
| 50mg | Discontinued | Request information | |
| 100mg | Discontinued | Request information | |
| 250mg | Discontinued | Request information | |
| 500mg | Discontinued | Request information |
